Pre-news from  Applied XL

Early signals in Aileron Therapeutic's ALRN-6924 program hinted at struggles for efficacy over a year before negative results

Did irregular shifts in clinical trial progression at Flagship’s Repertoire foreshadow the termination of its immuno-oncology program?

Could warning signs in Summit Therapeutics’ clinical trial activity have hinted at bad results months before they were announced?

Could early red flags in Takeda’s blood cancer program have signaled the failure of their next potential blockbuster?

How hidden signals in public data unveiled turmoil in one of the world’s most valuable biotech startups

Did hidden signals in data anticipate bad news for TG Therapeutics' clinical trial for chronic lymphocytic leukemia?

AppliedXL partners with STAT to launch a new clinical trials monitoring platform powered by artificial intelligence

Why we are building a real-time Information company powered by editorial algorithms